BoYen Therapeutics, Inc. (TPEX:7891)

Market Cap	452.72M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	19.43M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,011
Open	22.45
Previous Close	23.30
Day's Range	22.45 - 23.30
52-Week Range	19.20 - 40.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BoYen Therapeutics

BoYen Therapeutics, Inc., through its own proprietary prodrug technology platform, engages in drug research and discovery. The company’s products include BY-101, used for treating acute myeloid leukemia (AML), and BY-102 and BY-103, for the treatment of multiple sclerosis and acute hematologic malignancies. The company was founded in 2010 and is headquartered in Taipei, Taiwan.

• Industry: Pharmaceutical Preparations
• Founded: 2010
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7891

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 10, 2026

Data Sources Report a data error